Sumitomo Mitsui Trust Group Inc. Purchases 59,199 Shares of Humana Inc. $HUM

Key Points

• Sumitomo Mitsui Trust Group increased its stake in Humana by 20.1% in Q4, buying 59,199 shares to hold 354,424 shares (about $90.78 million or 0.29% of the company).
• Humana beat Q4 estimates, reporting EPS of ($3.96) versus ($4.01) expected and revenue of $32.64 billion (up 11.3% year-over-year), and the company set FY2026 EPS guidance at 9.00.
• Humana declared a quarterly dividend of $0.885 per share (annualized $3.54, yield ~1.8%) with an ex-dividend date of March 27 and payment on April 24.

Sumitomo Mitsui Trust Group Inc. boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 354,424 shares of the insurance provider's stock after acquiring an additional 59,199 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.29% of Humana worth $90,779,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Sound View Wealth Advisors Group LLC grew its holdings in Humana by 3.5% in the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider's stock worth $272,000 after acquiring an additional 36 shares during the last quarter. Unison Advisors LLC boosted its stake in shares of Humana by 0.4% during the 3rd quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider's stock valued at $2,646,000 after purchasing an additional 37 shares in the last quarter. CoreCap Advisors LLC boosted its stake in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 37 shares in the last quarter. Insigneo Advisory Services LLC boosted its stake in shares of Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider's stock valued at $386,000 after purchasing an additional 43 shares in the last quarter. Finally, Columbus Macro LLC boosted its stake in shares of Humana by 5.5% during the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider's stock valued at $210,000 after purchasing an additional 43 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Trading Up 3.1%

Shares of NYSE HUM opened at $198.18 on Tuesday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.35. The stock has a market cap of $23.79 billion, a P/E ratio of 20.18, a price-to-earnings-growth ratio of 2.06 and a beta of 0.44. The firm has a 50-day moving average of $180.77 and a 200 day moving average of $232.18. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company had revenue of $32.64 billion during the quarter, compared to analysts' expectations of $32.08 billion. During the same period last year, the company posted ($2.16) EPS. Humana's revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, March 27th. Humana's dividend payout ratio (DPR) is 36.05%.

Analysts Set New Price Targets

HUM has been the topic of a number of research reports. Sanford C. Bernstein reaffirmed an "outperform" rating and set a $344.00 target price on shares of Humana in a research note on Tuesday, January 6th. Evercore lifted their target price on shares of Humana from $180.00 to $195.00 in a research note on Wednesday, April 8th. TD Cowen cut their target price on shares of Humana from $260.00 to $173.00 and set a "hold" rating on the stock in a research note on Friday, February 13th. Raymond James Financial cut their target price on shares of Humana from $340.00 to $230.00 and set an "outperform" rating on the stock in a research note on Friday, February 13th. Finally, Morgan Stanley set a $146.00 target price on shares of Humana in a research note on Thursday, February 12th. Seven analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Humana presently has an average rating of "Hold" and a consensus target price of $224.65.

Insider Transactions at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was bought at an average cost of $185.21 per share, with a total value of $150,020.10. Following the transaction, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.20% of the stock is currently owned by company insiders.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.